Trials / Terminated
TerminatedNCT04529954
Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion
An Open-Label Extension Study to Investigate the Long-Term Safety, and Tolerability of Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Cerebral Therapeutics LLC · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-randomized open-label extension study for subjects having completed protocol DA071976 or CLN100P.01.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valproic Acid delivered to ICV | Valproic Acid delivered to ICV via an implantable pump and catheter system |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
- First posted
- 2020-08-28
- Last updated
- 2024-03-13
Locations
8 sites across 2 countries: Australia, Israel
Source: ClinicalTrials.gov record NCT04529954. Inclusion in this directory is not an endorsement.